COX-2 inhibitors and cardiovascular risk: The data are inconclusive, and these drugs are neededNovember 1, 2001CardiologyDrug TherapyRheumatologyVascular
COX-2 inhibitors and cardiovascular risk: We defend our data and suggest cautionNovember 1, 2001CardiologyDrug TherapyRheumatologyVascular
COX-2 inhibitors: Balancing the hope, the hype, and the concernNovember 1, 2001CardiologyVascularPreventive CareDrug Therapy
Management of primary headache: Serendipity and scienceNovember 1, 2001PainDrug TherapyNeurologyVascular
Chronic myelogenous leukemia: The news you have and haven't heardNovember 1, 2001HematologyImmunologyDrug Therapy
Recognizing and treating diabetic autonomic neuropathyNovember 1, 2001DiabetesNeurologyPainDrug TherapyGastroenterologyDermatologyNephrology
Role of alendronate and risedronate in preventing and treating osteoporosisNovember 1, 2001RheumatologyPreventive CareDrug TherapyGeriatricsWomen's HealthEndocrinology
A 44-year-old man with a pruritic skin rashNovember 1, 2001DermatologyDrug TherapyInfectious Diseases
Who should receive hepatitis A vaccine?October 1, 2001HepatologyInfectious DiseasesDrug TherapyImmunology
Elusive syndromes: Treating the biologic basis of fibromyalgia and related syndromesOctober 1, 2001PainDrug Therapy
At what level of hyperkalemia or creatinine elevation should ACE inhibitor therapy be stopped or not started?September 1, 2001CardiologyDrug TherapyNephrologyVascular
Physician's guide to popular low-carbohydrate weight-loss dietsSeptember 1, 2001Drug TherapyObesityPreventive CareEndocrinology
The dangers of self-monitored dieting: What are our patients really doing?September 1, 2001ObesityPreventive CareDrug TherapyEndocrinology
In-stent restenosis: Update on intracoronary radiotherapySeptember 1, 2001CardiologyDrug TherapyVascular
